Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th 1 mediated experimental colitis

Fantini, M. C.; Becker, C.; Tubbe, I.; Nikolaev, A.; Lehr, H. A.; Galle, P.; Neurath, M. F.
May 2006
Gut;May2006, Vol. 55 Issue 5, p671
Academic Journal
Background and aims: The imbalance between effector and regulatory T cells plays a central role in the pathogenesis of inflammatory bowel diseases. In addition to the thymus, CD4+CD25+ regulatory T cells can be induced in the periphery from a population of CD25-T cells by treatment with transforming growth factor β (TGF-β). Here, we analysed the in vivo function of TGF-β induced regulatory T (Ti-Treg) cells in experimental colitis. Methods: Ti-Treg cells were generated in cell culture in the presence or absence of TGF-β and tested far their regulatory potential in experimental colitis using the CD4+CD62L+ T cell transfer model. Results: Ti-Treg cells significantly suppressed Th1 mediated colitis on CD4+CD62L+ T cell transfer in vivo, as shown by high resolution endoscopy, histology, immunohistochemistry, and cytokine analysis. Further analysis of in vivo and in vitro expanded Ti-Treg cells showed that exogenous interleukin 2 (IL-2) was crucial far survival and expansion of these cells. Conclusion: Our data suggest that regulatory Ti-Treg cells expand by TGF-β and exogenous IL-2 derived from effector T cells at the site of inflammation. In addition to Tr1 and thymic CD4+CD25+ T cells, peripheral Ti-Treg cells emerge as a class of regulatory T cells with therapeutic potential in T cell mediated chronic intestinal inflammation.


Related Articles

  • Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Jauch, Dominik; Martin, Maria; Schiechl, Gabriela; Kesselring, Rebecca; Schlitt, Hans Jürgen; Geissler, Edward K.; Fichtner-Feigl, Stefan // Gut;Dec2011, Vol. 60 Issue 12, p1678 

    Background and aims: Colitis-associated tumorigenesis is a balance between proliferation of tumour cells and tumour immunosurveillance. The role of T-helper-cellderived cytokines in tumour growth is not fully understood. In this study the authors investigated the influence of interleukin (IL) 21...

  • Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines. Loewen, Gregory M.; Tracy, Erin; Blanchard, Frédéric; Dongfeng Tan; Jihnhee Yu; Raza, Sameera; Matsui, Sei-Ichi; Baumann, Heinz // BMC Cancer;2005, Vol. 5, p145 

    Background: Inflammation is commonly associated with lung tumors. Since inflammatory mediators, including members of the interleukin-6 (IL-6) cytokine family, suppress proliferation of normal epithelial cells, we hypothesized that epithelial cells must develop mechanisms to evade this inhibition...

  • Mucosal T cells as a target for treatment of IBD. Watanabe, Mamoru; Yamazaki, Motomi; Kanai, Takanori // Journal of Gastroenterology;2003 Supplement 15, Vol. 38, p48 

    Interleukin-7 (IL-7) is an indispensable cytokine for the development of lymphocyte lineage cells. However, the potential role of IL-7 in peripheral nonlymphoid tissues was unclear before our study. We have demonstrated that intestinal epithelial cells produce IL-7 and that IL-7 serves as a...

  • Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer. Kesselring, Rebecca; Jauch, Dominik; Fichtner-Feigl, Stefan // OncoImmunology;Jul2012, Vol. 1 Issue 4, p537 

    The pathogenesis of colitis-associated colorectal cancer is strongly influenced by immune cells, cytokines and other immune mediators present in the inflamed colon. Current research has emerged that T helper cell associated cytokines play a prominent role in tumor growth. In our recent...

  • New Insights into the Immunological Changes in IL-10-Deficient Mice during the Course of Spontaneous Inflammation in the Gut Mucosa. Gomes-Santos, Ana Cristina; GarciasMoreira, Thais; Castro-Junior, Archimedes Barbosa; Horta, Bernardo Coelho; Lemos, Luisa; Cruz, Deborah Nogueira; Freitas Guimarães, Mauro Andrade; Cara, Denise Carmona; Donna-Marie, McCafferty; Faria, AnaMaria Caetano // Clinical & Developmental Immunology;2012, p1 

    IL-10 is a regulatory cytokine that plays a major role in the homeostasis of the gut and this is illustrated by the fact that IL- 10-/- mice develop spontaneous colitis. In this study, IL-10-/- mice were analyzed for immunological changes during colitis development. We found a reduced frequency...

  • Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis. In Hye Jung; Hyun-Kyu Choi, Jeffrey; Yong-Yoon Chung; Ga-Lam Lim; Young-Nyun Park; Seung Woo Park // Neoplasia;Jul2015, Vol. 17 Issue 7, p586 

    Chronic inflammation is an important process leading to tumorigenesis. Therefore, targeting and controlling inflammation can be a promising cancer therapy. Inflammation is often caused by a variety of inflammatory cytokine such as the interleukin (IL)-6, a pleiotrophic cytokine known to be...

  • Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases. Owaga, Eddy; Hsieh, Rong-Hong; Mugendi, Beatrice; Masuku, Sakhile; Chun-Kuang Shih; Jung-Su Chang // International Journal of Molecular Sciences;Sep2015, Vol. 16 Issue 9, p20841 

    Inflammatory bowel diseases (IBD) are characterized by wasting and chronic intestinal inflammation triggered by various cytokine-mediated pathways. In recent years, it was shown that T helper 17 (Thu) cells are involved in the pathogenesis of IBD, which makes them an attractive therapeutic...

  • Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. Ishiguro, Yoh // Journal of Gastroenterology;1999, Vol. 34 Issue 1, p66 

    Abstract: Proinflammatory cytokines are believed to be involved in the pathogenesis of ulcerative colitis (UC). The aim of this study was to clarify the profiles of proinflammatory cytokine production in patients with UC in terms of disease intractability, endoscopic findings, and host response...

  • IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Leung, J M; Davenport, M; Wolff, M J; Wiens, K E; Abidi, W M; Poles, M A; Cho, I; Ullman, T; Mayer, L; Loke, P // Mucosal Immunology (1933-0219);Jan2014, Vol. 7 Issue 1, p124 

    T helper type (Th17) cytokines such as interleukin (IL)-17A and IL-22 are important in maintaining mucosal barrier function and may be important in the pathogenesis of inflammatory bowel diseases (IBDs). Here, we analyzed cells from the colon of IBD patients and show that Crohn's disease (CD)...


Read the Article


Sign out of this library

Other Topics